NCT01627041 2026-03-18Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 2 Active not recruiting178 enrolled
NCT00534469 2025-12-02Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep RCity of Hope Medical CenterPhase 2 Completed60 enrolled 9 charts